Skip to main content

ORBIMED ADVISORS LLC

Position in ALXO — Alx Oncology Holdings Inc

CIK 1055951 New York, NY

Position in ALXO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,746,843
-$5,676,762 QoQ
Shares Held
2,866,256
+51.3% QoQ
Ownership
2.13%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#12
of 68 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority Sole 46.683059712740246.ToString("F0")% Shared 0.ToString("F0")% None 53.316940287259754.ToString("F0")%

Common Shares in ALXO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. ALXO ranks #57 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALXO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,746,843 2,866,256
2024-06-30 $11,423,605 1,894,462
2024-03-31 $30,305,365 2,717,970
2023-12-31 $46,084,550 3,095,000
2023-09-30 $13,780,800 2,871,000
2023-06-30 $21,561,210 2,871,000
2023-03-31 $12,976,920 2,871,000
2022-12-31 $32,356,170 2,871,000
2022-09-30 $27,475,470 2,871,000
2022-06-30 $17,686,916 2,186,269
2022-03-31 $10,506,730 621,700
2021-12-31 $4,461,324 207,600
2021-09-30 $11,079,000 150,000
2021-06-30 $8,202,000 150,000
2021-03-31 $11,061,000 150,000
2020-12-31 $12,930,000 150,000